Profil bibliographique

Elizve Barrientos-Toro

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

13Publications signalées

34Citations signalées

1Affiliations récentes

Institutions déclarées

The University of Texas MD Anderson Cancer Center

Domaines associés

Breast Cancer Treatment StudiesHER2/EGFR in Cancer ResearchCalcium signaling and nucleotide metabolismCancer Immunotherapy and BiomarkersCancer Cells and Metastasis

Publications récentes

2026 conference-abstractOpenAlex

Abstract 7432: Spatial protein profiling of irradiated ER positive breast cancer lymph nodes suggests nodal irradiation modulates immune function

Stephanie O. Dudzinski, Elizve Barrientos-Toro, Benjamin Smith, Simona F. Shaitelman et autres

0 citationsCancer Research

2026 conference-abstractOpenAlex

Abstract 3884: Multiplex immunofluorescence based spatial analysis of HER2 positive breast cancer patients treated with bintrafusp alfa: A translational pathology study.

Maria Gabriela Raso, Elizve Barrientos-Toro, June Li, Renganayaki Pandurengan et autres

0 citationsCancer Research

Accès ouvert 2025 conference-abstractOpenAlex

Characterization of the immune microenvironment and spatial phenotypes across HER2 subtypes in advanced or metastatic breast cancer.

Ayse Aslihan Koksoy, Burak Uzunparmak, Gabriela Raso, Raymond P. Perez et autres

0 citationsJournal of Clinical Oncology

2025 conference-abstractOpenAlex

Abstract 4613: Differential TROP2 immunohistochemical expression between pleomorphic and classic invasive lobular carcinoma of the breast

Elizve Barrientos-Toro, Harsh Vardhan Batra, Pandurengan Renganayaki, Jason Mouabbi et autres

0 citationsCancer Research

Accès ouvert 2025 otherOpenAlex

Data from Accumulation of CD38 in Hybrid Epithelial/Mesenchymal Cells Promotes Immune Remodeling and Metastasis in Breast Cancer

Tanvi H. Visal, Recep Bayraktar, Petra den Hollander, Michael A. Attathikhun et autres

0 citations

Accès ouvert 2025 supplementary-materialsOpenAlex

Supplementary Data from Accumulation of CD38 in Hybrid Epithelial/Mesenchymal Cells Promotes Immune Remodeling and Metastasis in Breast Cancer

Tanvi H. Visal, Recep Bayraktar, Petra den Hollander, Michael A. Attathikhun et autres

0 citations

2025 articleOpenAlex

118 Immunohistochemical Profiling of SLUG and ZEB1 in Metaplastic Breast Carcinoma: Insights into Histological Variability

Elizve Barrientos-Toro, Renganayaki Pandurengan, Wei-Ting Lu, Luisa M. Solis Soto et autres

0 citationsLaboratory Investigation

Accès ouvert 2025 articleOpenAlex

Accumulation of CD38 in Hybrid Epithelial/Mesenchymal Cells Promotes Immune Remodeling and Metastasis in Breast Cancer

Tanvi H. Visal, Recep Bayraktar, Petra den Hollander, Michael A. Attathikhun et autres

6 citationsCancer Research

Accès ouvert 2025 articleOpenAlex

A phase I study of temsirolimus in combination with metformin in patients with advanced or recurrent endometrial cancer

Jibran Ahmed, Bettzy Stephen, Muhammad Rizwan Khawaja, Yali Yang et autres

7 citationsGynecologic Oncology

Accès ouvert 2024 preprintOpenAlex

Aberrant expression of CD14 in breast tumor cells is associated with poor outcome

Hiroyuki Katayama, Rongzhang Dou, Ricardo A. Léon-Letelier, Ehsan Irajizad et autres

1 citationbioRxiv (Cold Spring Harbor Laboratory)

Accès ouvert 2024 conference-abstractOpenAlex

864 Exploration of the circulating immune microenvironment stratified by breast cancer subtype

June Li, H Otte, Maria Gabriela Raso, Elizve Barrientos-Toro et autres

0 citationsRegular and Young Investigator Award Abstracts

Accès ouvert 2024 articleOpenAlex

Heterogeneous Profile of ROR1 Protein Expression across Tumor Types

Maria Gabriela Raso, Elizve Barrientos-Toro, Kurt W. Evans, Yasmeen Q. Rizvi et autres

13 citationsCancers

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.